cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.23700794
title: Additional file 3 of Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing

description: Additional file 3: Table S1. Quality control statistics for sequencing. DCM, dilated cardiomyopathy; Q20, percentage of bases with a Phred score greater than 20 to the total bases; Q30, percentage of bases with a Phred score greater than 30 to the total bases. Table S2. The number of variants carried by each DCM patient before and after filtering. DCM, dilated cardiomyopathy. Table S3. Rare variants in high evidence genes identified in the Fuwai DCM HTx cohort. One TTN variant (NM_133379:exon46:c.C12949T:p.Q4317X) was predicted to be VUS since it affects only the Novex-3 isoform. Bold PMID represents the paper focused on the HTx patients. ACMG/AMP, American College of Medical Genetics and Genomics and the Association for Molecular Pathology; ACTC1, actin alpha cardiac muscle 1; ACTN2, actinin alpha 2; B, benign; BAG3, BAG cochaperone 3; DCM, dilated cardiomyopathy; DES, desmin; DSP, desmoplakin; FLNC, filamin C; HTx, heart transplantation; JPH2, junctophilin 2; LB, likely benign; LMNA, lamin A/C; LP, likely pathogenic; MYH7, myosin heavy chain 7; NEXN, nexilin F-actin binding protein; P, pathogenic; PLN, phospholamban; RBM20, RNA binding motif protein 20; SCN5A, sodium voltage-gated channel alpha subunit 5; TNNT2, troponin T2, cardiac type; TTN, titin; VUS, variant of unknown significance. Table S4. The clinical characterization of DCM in relation to P/LP variant status. Continuous variables are expressed as the mean ± SD values, and all categorical variables are depicted using relative frequency distributions. Disease course: months from symptom onset to heart transplantation. AF, atrial fibrillation; BAG3, BAG cochaperone 3; BMI, body mass index; DCM, dilated cardiomyopathy; FLNC, filamin C; IVS, interventricular septum; LAD, left atrial diameter; LMNA, lamin A/C; LP, likely pathogenic; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association classification; P, pathogenic; RVD, right ventricle diameter; TTN, titin. P value &lt; 0.05 = *, &lt; 0.01 = **. Table S5. Clinical characterization of DCM in patients with one P/LP variant and those with more than one P/LP variant. Continuous variables are expressed as the mean ± SD values, and all categorical variables are depicted using relative frequency distributions. Disease course: months from symptom onset to heart transplantation. AF, atrial fibrillation; BMI, body mass index; DCM, dilated cardiomyopathy; IVS, interventricular septum; LAD, left atrial diameter; LP, likely pathogenic; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association classification; P, pathogenic; RVD, right ventricle diameter.
DOI: 10.6084/m9.figshare.23700794.v1
title: Additional file 3 of Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing

description: Additional file 3: Table S1. Quality control statistics for sequencing. DCM, dilated cardiomyopathy; Q20, percentage of bases with a Phred score greater than 20 to the total bases; Q30, percentage of bases with a Phred score greater than 30 to the total bases. Table S2. The number of variants carried by each DCM patient before and after filtering. DCM, dilated cardiomyopathy. Table S3. Rare variants in high evidence genes identified in the Fuwai DCM HTx cohort. One TTN variant (NM_133379:exon46:c.C12949T:p.Q4317X) was predicted to be VUS since it affects only the Novex-3 isoform. Bold PMID represents the paper focused on the HTx patients. ACMG/AMP, American College of Medical Genetics and Genomics and the Association for Molecular Pathology; ACTC1, actin alpha cardiac muscle 1; ACTN2, actinin alpha 2; B, benign; BAG3, BAG cochaperone 3; DCM, dilated cardiomyopathy; DES, desmin; DSP, desmoplakin; FLNC, filamin C; HTx, heart transplantation; JPH2, junctophilin 2; LB, likely benign; LMNA, lamin A/C; LP, likely pathogenic; MYH7, myosin heavy chain 7; NEXN, nexilin F-actin binding protein; P, pathogenic; PLN, phospholamban; RBM20, RNA binding motif protein 20; SCN5A, sodium voltage-gated channel alpha subunit 5; TNNT2, troponin T2, cardiac type; TTN, titin; VUS, variant of unknown significance. Table S4. The clinical characterization of DCM in relation to P/LP variant status. Continuous variables are expressed as the mean ± SD values, and all categorical variables are depicted using relative frequency distributions. Disease course: months from symptom onset to heart transplantation. AF, atrial fibrillation; BAG3, BAG cochaperone 3; BMI, body mass index; DCM, dilated cardiomyopathy; FLNC, filamin C; IVS, interventricular septum; LAD, left atrial diameter; LMNA, lamin A/C; LP, likely pathogenic; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association classification; P, pathogenic; RVD, right ventricle diameter; TTN, titin. P value &lt; 0.05 = *, &lt; 0.01 = **. Table S5. Clinical characterization of DCM in patients with one P/LP variant and those with more than one P/LP variant. Continuous variables are expressed as the mean ± SD values, and all categorical variables are depicted using relative frequency distributions. Disease course: months from symptom onset to heart transplantation. AF, atrial fibrillation; BMI, body mass index; DCM, dilated cardiomyopathy; IVS, interventricular septum; LAD, left atrial diameter; LP, likely pathogenic; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association classification; P, pathogenic; RVD, right ventricle diameter.
DOI: 10.26180/23632293.v1
title: Mild non-invasive brain stimulation for apathy in Huntington's disease

description: Randomized and counterbalanced sequence of three sessions of transcranial alternating current stimulation (tACS) conducted at least 72 hours apart, with details as follows:<br> 1) 20 minutes and 2mA at the participants peak individualised alpha frequency;<br> 2) 20 minutes and 2mA at 2Hz (delta frequency);<br> 3) 20 minutes of sham (placebo) with 30 seconds 'fade in' followed by an immediate 30 seconds 'fade out'.<br> TACS is administered using a Startstim wireless hybrid electroencephalography(EEG)/transcranial current stimulation 8-channel system (Neuroelectrics, Spain).<br> EEG obtained via a 50-channel Neuroscan EEG system.<br> All data collection (baseline measures, resting and task-related EEG) and tACS administration is conducted by Marie-Claire Davis (Registered Psychologist with practice endorsement in Clinical Neuropsychology and PhD candidate).
DOI: 10.26180/23632296.v1
title: The Study for Mother-Infant Sleep (The SMILE Project): Reducing postpartum insomnia in first-time mothers.

description: A provisional psychologist trained in the study protocol under the supervision of a clinical psychologist, will interact with participants in the three intervention conditions via phone to personalise interventions, providing recommendations of certain modules through an orientation phone call which will take up to 90 minutes. Participants will be randomised into 1 of 3 conditions: (a) an infant sleep intervention, (b) a maternal sleep intervention, and (c) a control condition.<br> Group A: Participants in the infant sleep intervention condition will be asked to use a responsive bassinet from birth until their infant reaches 6 months postpartum. The bassinet (a) automatically emits white-noise sounds, (b) safely swaddles the infant, which is recommended by the American Academy of Pediatrics (APP) as the safest sleeping position for the prevention of Sudden Infant Death Syndrome, and (c) provides rhythmic ‘rocking’ motions when crying noises are detected. Importantly, the bassinet employs these strategies for a maximum of 3 minutes. If the infant does not settle within this time, the bassinet alerts adults for additional assistance via a mobile application (e.g., feeding, changing). Use of the responsive bassinet and mobile application will be measured using an Intervention Adherence and Usefulness questionnaire delivered at 8 weeks and 6 months postpartum to examine roles in treatment response. Bassinet status/usage data will also be collected using the mobile application.<br> Group B: The maternal sleep condition uses therapist-assisted self-help cognitive behavioural therapy for insomnia (CBT-I) to address maladaptive sleep-related cognitions and behaviours. Content of the intervention is delivered via the following three means, combined: (1) A 50-minute telephone session conducted by a provisional psychologist; (2) A series of emails containing text, graphics, and/or audio-based intervention components are delivered at 6 stages: 30 weeks and 35 weeks pregnancy, then 2 weeks, 2 months, 3 months, and 6 months postpartum. Each email will address a specific component of sleep disturbance relevant to women in the perinatal period (e.g. developing healthy sleep habits) via text and images, and may include links to audio-based mindfulness and relaxation exercises. All participants in Group B will receive the same emails, which have been specifically designed for this study. (3) Mothers who have difficulty applying the intervention materials can request brief email or telephone clarification from the provisional psychologist who conducted the initial session. Treatment adherence will be measured using an Intervention Adherence and Usefulness questionnaire delivered at 35-36 weeks of gestation, and 8 weeks and 6 months postpartum.<br> Treatment effects will be assessed at 5 time points: 26-32 weeks of gestation (T1), 35-36 weeks of gestation (T2), 8 weeks postpartum (T3), 6 months postpartum (T4), and 12 months postpartum (T5).
DOI: 10.26180/23632296
title: The Study for Mother-Infant Sleep (The SMILE Project): Reducing postpartum insomnia in first-time mothers.

description: A provisional psychologist trained in the study protocol under the supervision of a clinical psychologist, will interact with participants in the three intervention conditions via phone to personalise interventions, providing recommendations of certain modules through an orientation phone call which will take up to 90 minutes. Participants will be randomised into 1 of 3 conditions: (a) an infant sleep intervention, (b) a maternal sleep intervention, and (c) a control condition.<br> Group A: Participants in the infant sleep intervention condition will be asked to use a responsive bassinet from birth until their infant reaches 6 months postpartum. The bassinet (a) automatically emits white-noise sounds, (b) safely swaddles the infant, which is recommended by the American Academy of Pediatrics (APP) as the safest sleeping position for the prevention of Sudden Infant Death Syndrome, and (c) provides rhythmic ‘rocking’ motions when crying noises are detected. Importantly, the bassinet employs these strategies for a maximum of 3 minutes. If the infant does not settle within this time, the bassinet alerts adults for additional assistance via a mobile application (e.g., feeding, changing). Use of the responsive bassinet and mobile application will be measured using an Intervention Adherence and Usefulness questionnaire delivered at 8 weeks and 6 months postpartum to examine roles in treatment response. Bassinet status/usage data will also be collected using the mobile application.<br> Group B: The maternal sleep condition uses therapist-assisted self-help cognitive behavioural therapy for insomnia (CBT-I) to address maladaptive sleep-related cognitions and behaviours. Content of the intervention is delivered via the following three means, combined: (1) A 50-minute telephone session conducted by a provisional psychologist; (2) A series of emails containing text, graphics, and/or audio-based intervention components are delivered at 6 stages: 30 weeks and 35 weeks pregnancy, then 2 weeks, 2 months, 3 months, and 6 months postpartum. Each email will address a specific component of sleep disturbance relevant to women in the perinatal period (e.g. developing healthy sleep habits) via text and images, and may include links to audio-based mindfulness and relaxation exercises. All participants in Group B will receive the same emails, which have been specifically designed for this study. (3) Mothers who have difficulty applying the intervention materials can request brief email or telephone clarification from the provisional psychologist who conducted the initial session. Treatment adherence will be measured using an Intervention Adherence and Usefulness questionnaire delivered at 35-36 weeks of gestation, and 8 weeks and 6 months postpartum.<br> Treatment effects will be assessed at 5 time points: 26-32 weeks of gestation (T1), 35-36 weeks of gestation (T2), 8 weeks postpartum (T3), 6 months postpartum (T4), and 12 months postpartum (T5).
description: HeSANDA 1.0.0
DOI: 10.26180/23632305.v1
title: Partners in Parenting: Evaluating the real-world use and impact of an online tailored parenting program for parents of adolescents.

description: An open access trial examining the effects of an individually-tailored, web-based parenting program (Partners in Parenting) for parents of 12-to-17-year-olds to reduce risk and protective factors for adolescent depression and anxiety disorders. <br> This study is linked to the following two previous trials. These trials were RCTs of the program being evaluated in the current open access trial. <br> ACTRN12615000328572 was an RCT evaluating the full Partners in Parenting program for parents of adolescents, compared to an active control condition (educational materials). <br> ACTRN12615000247572 was an RCT of a brief version of the Partners in Parenting program (single session, pesonalised feedback only), compared to a waitlist control.
DOI: 10.26180/23632305
title: Partners in Parenting: Evaluating the real-world use and impact of an online tailored parenting program for parents of adolescents.

description: An open access trial examining the effects of an individually-tailored, web-based parenting program (Partners in Parenting) for parents of 12-to-17-year-olds to reduce risk and protective factors for adolescent depression and anxiety disorders. <br> This study is linked to the following two previous trials. These trials were RCTs of the program being evaluated in the current open access trial. <br> ACTRN12615000328572 was an RCT evaluating the full Partners in Parenting program for parents of adolescents, compared to an active control condition (educational materials). <br> ACTRN12615000247572 was an RCT of a brief version of the Partners in Parenting program (single session, pesonalised feedback only), compared to a waitlist control.
description: HeSANDA 1.0.0
DOI: 10.6084/m9.figshare.23694675
title: data and codes

description: This is the street view image and eye movement data about urban perception research. Where the experimental dataset is the eye movement metrics data obtained after eye movement experiments and its corresponding image semantic segmentation results. The prediction dataset is the semantic segmentation results of all street view images.
DOI: 10.6084/m9.figshare.23694675.v2
title: data and codes

description: This is the street view image and eye movement data about urban perception research. Where the experimental dataset is the eye movement metrics data obtained after eye movement experiments and its corresponding image semantic segmentation results. The prediction dataset is the semantic segmentation results of all street view images.
DOI: 10.6084/m9.figshare.23694675.v1
title: data and codes

description: This is the street view image and eye movement data about urban perception research. Where the experimental dataset is the eye movement metrics data obtained after eye movement experiments and its corresponding image semantic segmentation results. The prediction dataset is the semantic segmentation results of all street view images.
DOI: 10.6084/m9.figshare.23700051
title: The processed FPKM files of RNA-seq data for the MA-LN and MA-K cell lines

description: MA-LN refers to the <em>Eμ-Myc;Cdkn2a-/-</em> cell line in this study. The MA-K cell line was established from MA-LN in our lab. MA-LN Lymphoma typically presented in lymph nodes (LNs) in recipient mice. MA-K lymphoma was mainly disseminated at the kidney, and LNs, spleens were no longer involved in recipient mice.
DOI: 10.6084/m9.figshare.23700051.v1
title: The processed FPKM files of RNA-seq data for the MA-LN and MA-K cell lines

description: MA-LN refers to the <em>Eμ-Myc;Cdkn2a-/-</em> cell line in this study. The MA-K cell line was established from MA-LN in our lab. MA-LN Lymphoma typically presented in lymph nodes (LNs) in recipient mice. MA-K lymphoma was mainly disseminated at the kidney, and LNs, spleens were no longer involved in recipient mice.
DOI: 10.6084/m9.figshare.22237561
title: Climate-resilient Tree Species

description: Expert arborists, botanists, and horticulturists assessed 220 tree species based on criteria related to urban suitability, climate resilience/vulnerability, and additional benefits as part of a study on the climate resilience of urban tree species in Peninsular Malaysia. All species in this dataset are trees, shrubs, and palms commonly found in urban and rural areas of Malaysia, compiled from four independent sources. <br> Expert knowledge was derived from various sources, including published evidence from primary or grey literature, direct observations (e.g., during weather events like floods), or inferences based on observations of ecologically similar species or known ecological factors (e.g., geographical range or habitat associations). <br> The fixed dataset used for the study has been archived on FigShare to ensure its long-term availability. For the most updated data, practitioners should refer to the Atlas of Climate Resilient Tree Species (ACResT) at www.acrest.com.my. ACResT is an open and collaborative online database that consolidates data on tree species. The assessments for the 220 species mentioned above have also been published on ACResT to encourage review by a broader group of practitioners. Additionally, ACResT allows for the entry and assessment of other tree species found in Malaysia, Singapore, or Indonesian Borneo. <br> We invite all tree experts, including arborists, botanists, horticulturists, landscape architects, and enthusiasts, to join ACResT. While the tree assessment process is thorough and robust, certification by an accredited organization is not required to join. We acknowledge the diverse backgrounds of knowledge holders and will evaluate each registration on a case-by-case basis.
DOI: 10.21227/w94d-qa50
title: Leakage point concentration data

description: This dataset contains data collected from multiple paths, such as Unequally space path, Curved path, ESPLB, data collected from actual paths, and concentration prediction data. This experiment adopts a new concentration data collection path ESBLP method efficiently divides the study area into three parts and measures concentration data along the boundaries to calculate gradients. This allows for the approximate positioning of the leak point within its corresponding region.Based on the data collected above, the MGA algorithm is used to process it, obtain the backcalculated coordinates of the leakage point, and then compare it with the actual leakage point position to determine which path is more optimal
DOI: 10.25340/r4/xz5rlo
title: Related Data for: Crossover gait in running and measuring foot inversion angle at initial foot strike: A front-view video analysis approach

description: Introduction: Foot inversion angle at initial foot strike is associated with various running-related injuries. Traditionally, video analysis of foot inversion angle has been accomplished by positioning a camera to record from the back view, but complications arise when a crossover gait obscures the area of measurement. This study aims to investigate the viability of measuring foot inversion angles at initial foot strike of running from the front view as an alternative to using the back view in 2D video analysis. Methods: Forty-four healthy runners (20 females, 24 males) ran at their self-selected speeds on a treadmill with their gait recorded from front and back camera views. Foot inversion angles at initial foot strike were analyzed using Kinovea. A 2 × 2 (Camera × Foot) ANOVA with repeated measures was performed on the foot inversion angle data. Subsequently, correlation and linear regression were performed to determine the relationship between the back and front-view measurements. Results: Thirteen runners (29.5%) displayed crossover gait within 18 gait cycles. ANOVA revealed a significant main effect on Camera (p &lt; .001) only, where foot inversion angle was greater from the front camera view. Correlation analysis showed a significant positive correlation between the front and back camera views (r = 0.388, p &lt; .001). Regression analyses yielded an equation, y = 0.42 + 0.53 x, where y and x were the foot inversion angle measured from the back and front camera views, respectively. Discussion: With a linear regression conversion equation, front-view foot inversion angles at initial foot strike can be used to determine rearfoot inversion angles when crossover gait obstructs the back camera view.
DOI: 10.25345/c5w669k27
title: MassIVE MSV000092463 - GNPS- LC-MS/MS datafiles of VIB diterpenoids
title: This is the LC-MS/MS data of natural products for VIB diterpenoids.
DOI: 10.21227/0e4c-zc53
title: Electromyography Analysis of Human Activities - DataBase 2 

description: We present a sEMG signal database corresponding to the Indian population named “ElectroMyography Analysis of Human Activities - DataBase -2 (EMAHA-DB2).” This data set consists of two different weight training activities which involve isotonic and isometric contractions. Weight training activities are effective for improving muscle strength, overall health, and regaining limb functionality for people undergoing rehabilitation post stroke-related episodes. The EMG signals acquired during weight training can be used for muscle recruitment analysis. For example, during a specific movement, it can determine the set of recruited muscles and their order of recruitment. The institutional ethics committee of Indian Institute of Information Technology Sri City (No. IIITS/EC/2022/01) approved the proposed data collection protocol developed in accordance with the declaration of Helsinki and the “National Ethical Guidelines for Biomedical and Health Research involving human participants" of India. Nine healthy male subjects with no history of upper limb pathology participated in the sEMG data collection process. The average age is 21 years. Before the first session of activities, each of the participants gave written informed consent and the data collection process is completely non-invasive. At the beginning of each session, the participant's hands are cleaned with an alcohol based wet wipe. The total duration of each session is up-to one hour per subject depending on adaptability. Each of the hand muscle activity is recorded with a 2-channel Noraxon Ultium wireless sEMG sensor setup. Two self-adhesive Ag/AgCL dual electrodes were placed at Biceps Brachi(BB) and Flexor carpi ulnaris (FCU) muscle locations. During an activity, the subject is in a standing position and the weight is placed on a table at a convenient height for pickup. Each activity has three phases: rest followed by action and release. Each activity is repeated nine times. In order to avoid muscle fatigue, subjects rest for two minutes between different activities. (2022-12-20)